Due to the fact those who carry the APOE e4 gene variant appear to have a greater danger of serious problems, the FDA suggests remaining tested for the gene variant before beginning treatment with lecanemab or donanemab.Free Shipping Announcement Free delivery on all orders above $forty five* See Facts Open more particulars modal Absolutely free r